Respiratory Muscle Training and Quality of Life in Hemodialysis Patients
NCT ID: NCT07183696
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2024-10-01
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Intradialytic Inspiratory Muscle Training on Functional Capacity in Hemodialysis Patients
NCT07094347
Respiratory Training in Hemodialysis Patients
NCT03153124
Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis
NCT05241652
Inspiratory Muscle Training in Patients With End-stage Renal Disease
NCT02599987
Two Different Renal Rehabilitation Protocols in Hemodialysis Patients
NCT06838299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study aims to:
Investigate the effect of the Breath Booster device on respiratory muscle strength in patients undergoing dialysis.
Evaluate the impact of the Breath Booster device on the quality of life of patients undergoing dialysis.
Assess the effect of the Breath Booster device on exercise capacity in dialysis patients.
Significance of the study The burden of chronic kidney disease (CKD) in Egypt has increased significantly over the past decade, with a 36% rise in cases between 2009 and 2019. CKD is now the fifth leading cause of death in the country, highlighting the urgent need for effective patient-centered interventions. A 2024 report underscored the importance of implementing a comprehensive renal registry to improve patient outcomes and lessen the healthcare burden.
Hemodialysis patients face substantial challenges, including adherence to strict dietary and fluid restrictions, repeated dialysis sessions each week, and vascular access care. These lifestyle demands often contribute to reduced physical function, lower quality of life, and increased psychological stress.
Moreover, respiratory muscle weakness is a common complication among CKD patients, particularly those on hemodialysis. This impairment reduces functional capacity and negatively impacts quality of life. Inspiratory muscle training (IMT) has recently emerged as a promising, non-pharmacological method to address this issue.
Given these factors, the present study seeks to evaluate the effectiveness of the Breath Booster device in improving respiratory muscle strength, quality of life, and exercise capacity in hemodialysis patients.
Delimitation
This study will be delimited to:
Forty patients participating in the study. Age range between 50-60 years. Patients diagnosed with end-stage renal disease (CKD stage 5) on hemodialysis. Patients who have been undergoing regular hemodialysis for 1-3 years.
Null Hypothesis There will be no significant effect of Breath Booster training on respiratory muscle strength and quality of life in hemodialysis patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
will receive respiratory physical therapy sessions in the form of breathing exercises, chest percussion, and vibration 3 times per week during dialysis sessions for 6 weeks
breathing exercises
* breathing exercises as needed 3 times per week during dialysis sessions.
* chest percussion as needed 3 times per week during dialysis sessions.
* vibration as needed 3 times per week during dialysis sessions.
Intervention Group
will receive respiratory physicaltherapy sessions in the form of breathing exercises, chest percussion, and vibration 3 times per week during dialysis sessions for 6 weeks and training on the breath booster device at the same session
breathing exercises
* breathing exercises as needed 3 times per week during dialysis sessions.
* chest percussion as needed 3 times per week during dialysis sessions.
* vibration as needed 3 times per week during dialysis sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
breathing exercises
* breathing exercises as needed 3 times per week during dialysis sessions.
* chest percussion as needed 3 times per week during dialysis sessions.
* vibration as needed 3 times per week during dialysis sessions.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Their ages will range from 50 to 60 years.
3. Patients with end-stage renal disease (grade 5) receiving hemodialysis.
4. Patients on hemodialysis for around 1 to 3 years.
5. They will be able to follow instructions during evaluation and treatment.
Exclusion Criteria
2. Morbid obesity with a BMI of more than 35 kg/m2.
3. Hearing or visual impairments.
4. Any severe chest diseases like COPD.
5. Certain contraindications for the use of the Breath Booster. Individuals with severe respiratory conditions such as unstable asthma, or emphysema, or those who have recently undergone lung surgery
6. Uncontrolled seizures.
50 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sameh Eldaly
director of scientific research committee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of physical therapy cairo university
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005826
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.